Skip to main content
. 2022 Aug 25;14(9):1773. doi: 10.3390/pharmaceutics14091773
3D three-dimensional
5-FU 5-fluorouracil
AAP Auricularia auricula polysaccharides
ADC antibody-drug conjugate
ADEPT antibody-directed prodrug therapy
ADH adipohydrazide
CDDP cis-diamminedichloroplatinum (II)
CTR centyrin
CTS chitosan
CTS-NPs Hase-chitosan NPs
CHS cholesterol
CM-PL carboxymethyl pullulan
DA deoxycholic acid
DEX Dextran
DOX doxorubicin
DS dextran-spermine
DSPIONs dextran-coated superparamagnetic iron oxide NPs
DTX docetaxel
EPR enhanced permeability and retention
FA folic acid
FGFR1 fibroblast growth factor receptors
FR folate receptor
GDEPT gene-directed enzyme prodrug
GEM gemcitabine
Gly glycine
HA hyaluronic acid
Hase hyaluronidase
HEP heparinHis histidine
HPMA 2-hydroxypropyl methacrylate
IC50 half-maximal inhibitory concentration
Ile isoleucine
KIT tyrosine-protein kinase
Leu leucine
LPNPs lipid-polymer hybrid nanoparticles
LYVE-1 lymphatic vessel endothelium receptor-1
MMP-2 matrix-metalloproteinase-2
MMP-9 matrix-metalloproteinase-9
MTX methotrexate
MYD88 myeloid differentiation factor 88
NP(s) nanoparticle(s)
oDex oxidized dextran
PDC polymer–drug conjugates
PDEPT polymer-directed enzyme prodrug therapy
PDGFR1 platelet-derived growth factor receptors
PDTC pyrrolidine dithiocarbamate
PeDC Peptide–drug conjugate
PELT polymer enzyme liposome therapy
PFEP poly{[9,9-bis(6′-(N,N,N-diethylmethylammonium)hexyl) 2,7-fluorenylene ethynylene]-alt-co-[2,5-bis(3′-(N,N,N-diethylmethylammonium)-1′-oxapropyl)-1,4-phenylene]} tetraiodide
Phe phenylalanine
PL pullulan
PLA pullulan acetate
PrDC protein-drug conjugate
Pro proline
PTX paclitaxel
RHAMM receptor for hyaluronan-mediated motility
S sorafenib
SELP silk-elastin-like polymer
SF silk fibroin
TiO2 NPs titanium dioxide nanoparticles
TLR4 toll-like receptor 4)
Val valine
VDEPT virus-directed enzyme prodrug therapy
VEGFR vascular endothelial growth factor